- Home
- EDBL vs AWH Comparison
EDBL vs AWH Comparison
Compare EDBL & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- AWH
- Stock Information
- Founded
- EDBL 2020
- AWH 1993
- Country
- EDBL United States
- AWH United States
- Employees
- EDBL N/A
- AWH N/A
- Industry
- EDBL Farming/Seeds/Milling
- AWH Medical/Dental Instruments
- Sector
- EDBL Consumer Staples
- AWH Health Care
- Exchange
- EDBL Nasdaq
- AWH Nasdaq
- Market Cap
- EDBL 6.8M
- AWH 6.2M
- IPO Year
- EDBL 2022
- AWH N/A
- Fundamental
- Price
- EDBL $0.22
- AWH $0.22
- Analyst Decision
- EDBL
- AWH Buy
- Analyst Count
- EDBL 0
- AWH 2
- Target Price
- EDBL N/A
- AWH $4.40
- AVG Volume (30 Days)
- EDBL 9.2M
- AWH 306.0K
- Earning Date
- EDBL 03-31-2025
- AWH 03-27-2025
- Dividend Yield
- EDBL N/A
- AWH N/A
- EPS Growth
- EDBL N/A
- AWH N/A
- EPS
- EDBL N/A
- AWH N/A
- Revenue
- EDBL $14,069,000.00
- AWH $8,963,000.00
- Revenue This Year
- EDBL $2.43
- AWH $11.87
- Revenue Next Year
- EDBL $42.42
- AWH $79.10
- P/E Ratio
- EDBL N/A
- AWH N/A
- Revenue Growth
- EDBL 7.88
- AWH N/A
- 52 Week Low
- EDBL $0.12
- AWH $0.21
- 52 Week High
- EDBL $12.47
- AWH $4.43
- Technical
- Relative Strength Index (RSI)
- EDBL 47.86
- AWH 21.26
- Support Level
- EDBL $0.16
- AWH $0.21
- Resistance Level
- EDBL $0.31
- AWH $0.36
- Average True Range (ATR)
- EDBL 0.03
- AWH 0.06
- MACD
- EDBL 0.00
- AWH -0.00
- Stochastic Oscillator
- EDBL 37.84
- AWH 4.76
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.